epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove ambrisentan
    generic
  • remove naproxen/ esomeprazole
    generic
  • remove Vanacof DM
    dextromethorphan/ phenylephrine/ guaifenesin
  • remove Vyepti (eptinezumab-jjmr)
    eptinezumab

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face naproxen/esomeprazole (generic) + Vanacof DM (dextromethorphan/ phenylephrine/ guaifenesin)

Monitor/Modify Tx


naproxen + phenylephrine

monitor BP: combo may incr. risk of HTN (additive effects)

Smiley face Smiley face naproxen/esomeprazole (generic) + Vyepti (eptinezumab-jjmr) (eptinezumab)

Monitor/Modify Tx


naproxen + eptinezumab

monitor BP: combo may incr. risk of HTN (additive effects)

Smiley face Smiley face Vanacof DM (dextromethorphan/ phenylephrine/ guaifenesin) + Vyepti (eptinezumab-jjmr) (eptinezumab)

Monitor/Modify Tx


phenylephrine + eptinezumab

monitor BP: combo may incr. risk of HTN (additive effects)

Additional Considerations

Smiley face Smiley face phenylephrine in Vanacof DM

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face dextromethorphan in Vanacof DM

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information